一、建设规模和内容
项目占地4公顷，选址武强县经济开发区，主要生产设备有巧克力浇注机、精磨机、包球机、烤箱等。预计项目达产后，年产裹衣花生1.5万吨、巧克力制品6000吨。
二、投资估算及资金来源
项目总投资7905万美元，拟利用外资3162万美元。
三、市场分析
随着居民消费水平的提高，我国休闲食品市场逐渐向年轻化、高端化、健康化升级。零食在未来的发展，将越来越贴近人们的生活习惯和饮食习惯。米果制品方便携带，利于消化和便于咀嚼，在当下越来越受大众的欢迎，市场前景广阔。
四、经济和社会效益
项目投产后，预计年产值8854万美元，实现收入6798万美元，利润870万美元，上交税金285万美元。
五、建设条件
项目选址在武强县经济开发区，开发区内基础设施建设良好，307国道、石黄高速公路横贯东西，106国道、大广高速公路、京九铁路延区而过，交通便利，条件优越。
六、中方承办单位概况
中澳贯虹河北生物医药科技发展有限公司于2014年11月注册，注册资本790万美元，公司经营范围是中草药种植、检测、分析、中药饮片加工，菊粉及菊粉附产品深加工等。2021年销售收入0.88亿美元，利税0.15亿美元。
七.合作方式
合资
八、联系方式
单位：河北省武强县开发区企业服务局
联系人及职务：井占永 局长
联系电话及传真：0318-3963666
电子邮箱：wqjjkfq@163.com
Comprehensive processing project of rice and fruit products
Construction scale and content: The project, located in the economic development zone in Wuqiang County, covers four hectares. It mainly produces chocolate cating machines, refiners, package ball machines, ovens, etc. After reaching production, it produces 15,000 tonnes of coated peanut and 6000 tones of chocolate products.
Investment estimation and capital source: The total investment of the project is 79.05 million U.S. dollars and the proposed foreign investment is 31.62 million U.S. dollars.
Market Analysis: With the improvement of the consumption level of residents, the leisure food market in China has gradually been becoming younger, high-end and healthy. The development of snacks in the future will be more and more close to people's living habits and eating habits. Rice and fruit products are convenient to carry, conducive to digestion and easy to chew. At present, they are more and more popular with the public and have a broad market prospect.
Economic and social benefit: After reaching production, it is estimated that the annual output value is 88.54 million US dollars, the revenue is 67.98 million US dollars, the profit is 8.7 million US dollars, and the tax is 2.85 million US dollars.
Construction conditions: The site of the project is located in Wuqiang Economic Development Zone, which has good infrastructures. National Highway 307 and Shijiazhuang-Huanghua Expressway cross the east and west, while National Highway 106, Daqing-Guangzhou Expressway and Beijing-Kowloon Railway pass through the zone, with convenient transportation and superior conditions.
Profile of organizer: China Macao Hebei Biomedical Technology Development Co., Ltd. was registered in November 2014, with a registered capital of 7.9 million US dollars. The company's business scope is Chinese herbal medicine cultivation, testing, analysis, processing of Chinese herbal decoction pieces, and deep processing of inulin and inulin supplementary products. In 2021, the sales revenue is 88 million U.S. dollars, with profits and taxes of 15 million U.S. dollars.
Way of cooperation: Joint venture
Contact: Jing Zhanyong 0318-3963666
Email:wqjjkfq@163.com
Editor: Song Lifang
